paxilline has been researched along with snx 482 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carabelli, V; Carbone, E; Mahapatra, S; Marcantoni, A; Sinnegger-Brauns, MJ; Striessnig, J; Vandael, DH | 1 |
1 other study(ies) available for paxilline and snx 482
Article | Year |
---|---|
Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Cortex; Adrenal Medulla; Animals; Biophysical Phenomena; Biophysics; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Chelating Agents; Chromaffin Cells; Dose-Response Relationship, Drug; Egtazic Acid; Electric Stimulation; Gene Expression Regulation; Indoles; Ionophores; Large-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Mice; Mice, Knockout; Patch-Clamp Techniques; Potassium Channel Blockers; Spider Venoms; Time Factors | 2010 |